High-Grade Glioma, NOS — Trials

High-Grade Glioma, NOS — Trials · CancerIndex

Clinical trials

Registered studies

173 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 75
Recruiting: 47
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Nationwide Children's Hospital
Termination share: 44.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (30)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05632562	Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma	recruiting	Early Phase 1	20	University of Alabama at BirminghamOTHER	1	Aug 20, 2026	clinicaltrials
NCT07210632	Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)	recruiting	Early Phase 1	38	Eben RosenthalOTHER	1	Jul 1, 2026	clinicaltrials